Site Group Page (References Reporting High Throughput Detection Method)
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Site Group Page (References Reporting High Throughput Detection Method)
 

Site Information
PSF (human) R695-m1 PAGYGRGrEEYEGPN 1, 2, 4, 5, 6, 7, 8, 13
PSF (mouse) R687-m1 PAGYGRGrEEYEGPN 1, 3, 11, 12, 14, 15, 16
PSF (rat) R687-m1 PAGYGRGrEEYEGPN 9, 10

References

1

Guo A, et al. (2014) Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13, 372-87
24129315   Curated Info

2

(2010) CST Curation Set: 9753; Year: 2010; Biosample/Treatment: cell line, HCT 116/control; Disease: colorectal carcinoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1 Antibody Used to Purify Peptides prior to MS2: Mono-Methyl Arginine (Me-R(4)-100) Rabbit mAb Cat#: 8015
Curated Info

3

(2010) CST Curation Set: 9115; Year: 2010; Biosample/Treatment: cell line, PY2/untreated; Disease: -; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

4

(2010) CST Curation Set: 9113; Year: 2010; Biosample/Treatment: cell line, NTERA-2/untreated; Disease: -; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

5

(2010) CST Curation Set: 9112; Year: 2010; Biosample/Treatment: cell line, NCCIT/untreated; Disease: -; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

6

(2010) CST Curation Set: 8862; Year: 2010; Biosample/Treatment: cell line, HCT 116/normal; Disease: colorectal carcinoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

7

(2010) CST Curation Set: 8863; Year: 2010; Biosample/Treatment: cell line, HCT 116/normal; Disease: colorectal carcinoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

8

(2010) CST Curation Set: 8860; Year: 2010; Biosample/Treatment: cell line, HCT 116/normal; Disease: colorectal carcinoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

9

(2009) CST Curation Set: 6812; Year: 2009; Biosample/Treatment: cell line, PC-12/NGF; Disease: pheochromocytoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

10

(2009) CST Curation Set: 6811; Year: 2009; Biosample/Treatment: cell line, PC-12/NGF; Disease: pheochromocytoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

11

(2009) CST Curation Set: 6009; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

12

(2009) CST Curation Set: 6008; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

13

(2008) CST Curation Set: 5149; Year: 2008; Biosample/Treatment: cell line, HCT116/Adox; Disease: colorectal carcinoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

14

(2008) CST Curation Set: 3812; Year: 2008; Biosample/Treatment: tissue, brain, embryonic/untreated; Disease: -; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

15

(2008) CST Curation Set: 3813; Year: 2008; Biosample/Treatment: tissue, heart/untreated; Disease: -; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

16

(2008) CST Curation Set: 3814; Year: 2008; Biosample/Treatment: tissue, liver/untreated; Disease: -; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.